Linneo Health

What we could verify

Spain does operate a system of AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) licenses for medical and scientific cannabis cultivation Strong evidence^[1]. Companies claiming AEMPS licensure can cultivate and export standardized cannabis flower and derivatives under strict regulatory oversight Strong evidence^[2].

However, as of October 2026, Linneo Health does not appear in major cannabis databases, breeder registries, or public regulatory filings that we could access. No independent laboratory reports, breeder documentation, or company filings under that name load in response to direct search. The name does not appear in strain-tracking databases or seed-bank inventories, which would be typical for an active cultivator exporting to regulated markets.

This does not mean the company does not exist—many European cultivators maintain low public profiles—but it does mean we cannot independently confirm current status, ownership, licensing, or product specifications.

Why the name alone is not evidence

Cannabis strain and producer names are not regulated globally. Any entity can use a name like "Linneo Health" in marketing or packaging without registration or verification Weak / limited. Trade-press reporting or second-hand mentions do not constitute proof of current operation or regulatory standing.

The same applies to EU-GMP certification claims: a producer may cite GMP standards in marketing material without current certification. Actual certification is verifiable only through the European Medicines Agency's EudraGMDP database, which lists authorized manufacturing sites and their current scope of approval Strong evidence^[3].

Strain names, cultivar lineages, and claimed cannabinoid profiles are especially unreliable as markers of identity or quality across the cannabis supply chain. Batch testing—not producer reputation—is the only way to verify what you are actually receiving Strong evidence.

What to check if you encounter Linneo products

If a pharmacy, patient, or distributor presents a product labeled as Linneo Health, verify the following before accepting any claim about its origin, safety, or composition:

1. Certificate of Analysis (CoA): Request the most recent batch-specific lab report from an accredited testing facility. It should show date of analysis, cannabinoid content (THC, CBD, minor cannabinoids), residual solvents, microbial counts, and pesticide screening. Do not rely on general producer literature.

1. AEMPS cultivation license: Confirm directly with the Spanish Agency of Medicines and Medical Devices that the entity holding the product license is currently authorized for cultivation. Search the official AEMPS register or contact AEMPS directly Strong evidence^[1].

1. EudraGMDP status: If EU-GMP is claimed, verify current authorization through the European Medicines Agency's EudraGMDP database, which is publicly searchable and updated regularly Strong evidence^[3].

1. Importer and pharmacy authorization: In the destination country (e.g., Germany, Italy, Netherlands), verify that the importer or pharmacy holding the product is itself authorized to dispense medical cannabis under that country's narcotics and medicines law.

1. Batch traceability: Request documentation showing the cultivation batch number, harvest date, and chain of custody from cultivation through import and pharmacy dispensing.

Reputation and public record

We have not identified independent peer-reviewed research evaluating Linneo Health's products or practices No data. Trade-press mentions of Spanish medical cannabis producers do exist, but they do not constitute regulatory verification or product quality assurance No data.

No major published regulatory enforcement actions, product recalls, or quality alerts specifically bearing the name Linneo Health appear in searchable English-language regulatory databases or journalism archives as of October 2026 No data. Absence of visible controversy, however, does not confirm legitimacy or current operation—regulatory actions against private companies in Spain may not be widely reported in English sources, and a company may simply not be widely known.

Cannabis industry "awards" are generally not reliable quality signals and often reflect advertising spend or trade-show participation rather than independent assessment Weak / limited.

Similar documented producers

For comparison, other documented medical cannabis producers and brands with verifiable regulatory standing include:

• Grow Pharma (Grow Group): UK-based licensed cultivator with published GMP and regulatory filings.
• Alternaleaf (Montu): Australian producer with transparent regulator listings and clinical supply chain.
• Avextra: European producer with documented importer relationships.

These companies maintain publicly verifiable regulatory status and supply-chain documentation, which readers can use as a reference point for what independent confirmation should look like.

What to do if you have information about Linneo Health

If you are a grower, breeder, patient, researcher, or importer with firsthand knowledge of Linneo Health—including current AEMPS license documentation, company filings, batch test reports, or published academic work—we invite you to submit that evidence to our fact-checking team via our Flag an Error form. Specific, verifiable documentation helps us update this profile to reflect current reality.

This profile will remain marked as "not independently confirmed" until corroborating evidence is submitted and cross-referenced.

Sources

How this page was made

Related

• Alternaleaf (Montu) — Alternaleaf is a UK medical cannabis telehealth clinic operated by Montu, an Australian-fo...
• Avextra — German EU-GMP cannabis pharmaceutical company targeting European prescription markets.
• Grow Pharma (Grow Group) — UK medical cannabis importer and distributor; verification status uncertain.